Chittenden-3-7 Vermont Representative District, 2002–12 of South Burlington is in Chittenden-3-8, Chittenden-3-9, and Chittenden-3-10. As of the 2000 census, the state as a whole had a population of 608,827. As there are a total of 150 representatives, there were 4,059 residents per representative (or 8,118 residents per two representatives). The one member Chittenden-3-7 District had a population of 3,721 in that same census, 8.33% below the state average. Chittenden-3-7 Vermont Representative District, 2002–12 The Chittenden-3-7 Representative District is a one-member state Representative district in the U.S. state of Vermont. It is one of the 108 one or two member districts into which the state was
7+3 (chemotherapy) anthracyclines. Addition of glucocorticoids (like prednisolone) or methotrexate or alkylating drugs (like cyclophosphamide or melphalan) to the "7+3" regimen is also of no benefit in AML. The addition of etoposide to the standard "7+3" regimen is "sometimes" of benefit in poor-risk patients (many of which are primary refractory to standard "7+3" induction regimens). It gave rise to the so-called ADE (or DAE = DA + etoposide) induction regimen in AML. The ADE induction (unlike, say, combinations of 7+3 with vinca alkaloids or prednisolone) is still sometimes used, especially in poor-risk AML patients. The addition of 6-thioguanine gave rise to the